Five‐year EuroQol 5‐Dimension Outcomes After Endoscopic Sinus Surgery

Male Adult Time Factors Endoscopy Middle Aged 03 medical and health sciences Treatment Outcome 0302 clinical medicine Surveys and Questionnaires Chronic Disease Quality of Life Humans Female Prospective Studies Sinusitis Rhinitis Follow-Up Studies Aged
DOI: 10.1002/lary.31206 Publication Date: 2023-12-21T12:30:40Z
ABSTRACT
ObjectiveThe EuroQol 5‐Dimension (EQ‐5D) is a general health survey that is quick to administer, widely used, and directly convertible to health utility values (HUV). We aim to describe the five‐year EQ‐5D outcomes among patients who undergo surgical treatment for chronic rhinosinusitis (CRS).Study DesignProspective observational cohort study.MethodsPatients with CRS completed the EQ‐5D questionnaire preoperatively and annually for five years following endoscopic sinus surgery. Paired t‐tests and McNemar's tests were used to compare preoperative and postoperative scores. Mixed‐effects modeling was used for multivariate analysis.ResultsAmong 1296 patients enrolled in our study, 812 (74.7%) completed the postoperative survey at one year and 336 (38.9%) completed it at five years. There was a significant and sustained reduction of patients reporting pain/discomfort (74.9% vs. 58.0%, p < 0.001) and anxiety/depression (49.6% vs. 38.1%, p = 0.01) out to five years. Frequency of problems reported in the usual activity domain decreased at one year and was sustained through year four (30.6% vs 19.7%, p = 0.003). After multivariable modeling, female gender (p = 0.02), prior sinus surgery (p = 0.01), tobacco use (p = 0.038), headaches (p = 0.013), allergies (p = 0.001), diabetes (p = 0.022), hypertension (p = 0.036), higher preoperative SNOT‐22 score (p < 0.001), and a lower preoperative Lund‐Mackay score (p < 0.001) were associated with significantly worse EQ‐5D HUV over time. Similarly, a worse EQ‐5D Visual Analog Scale (VAS) over time was associated with allergies (p = 0.03), diabetes (p < 0.001), hypertension (p = 0.04), higher preoperative SNOT‐22 score (p < 0.001), and prior sinus surgery (p < 0.001).ConclusionPatients with chronic rhinosinusitis experience significant sustained improvements in health‐related quality of life up to five years after ESS as measured by the EQ‐5D instrument.Level of EvidenceLevel 2 Laryngoscope, 134:2592–2601, 2024
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (41)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....